Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes | Zendy

Yang Xiao | Zendy; Aimin Xu | Zendy; Lawrence SiuChun Law | Zendy; Cheng Chen | Zendy; Hui Li | Zendy; Xia Li | Zendy; Lin Yang | Zendy; Shiping Liu | Zendy; Zhiguang Zhou | Zendy; Karen S.L. Lam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes

Author(s) -

Yang Xiao,

Aimin Xu,

Lawrence SiuChun Law,

Cheng Chen,

Hui Li,

Xia Li,

Lin Yang,

Shiping Liu,

Zhiguang Zhou,

Karen S.L. Lam

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-1930

Subject(s) - fgf21 , medicine , type 2 diabetes , endocrinology , diabetes mellitus , type 1 diabetes , autoantibody , fibroblast growth factor , immunology , antibody , receptor

Fibroblast growth factor (FGF) 21 is an endocrine factor with multiple beneficial effects on glucose and lipid metabolism in animals. This study aimed to investigate the association of serum FGF21 levels with type 1 diabetes, latent autoimmune diabetes in adults (LADA) and type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research